
<div id="jpedal" style="overflow: hidden; position: relative; width: 893px; height: 1196px;">
<style type="text/css" >
.t {
	-webkit-transform-origin: top left;
	-moz-transform-origin: top left;
	-o-transform-origin: top left;
	-ms-transform-origin: top left;
	-webkit-transform: scale(0.25);
	-moz-transform: scale(0.25);
	-o-transform: scale(0.25);
	-ms-transform: scale(0.25);
	z-index: 2;
	position:absolute;
	white-space:nowrap;
	overflow:visible;
}
</style>
<style type="text/css" >

#t1_4{left:58px;top:103px;letter-spacing:0.1px;word-spacing:2.4px;}
#t2_4{left:58px;top:121px;}
#t3_4{left:76px;top:140px;letter-spacing:0.1px;word-spacing:8.2px;}
#t4_4{left:58px;top:158px;word-spacing:3.6px;}
#t5_4{left:58px;top:176px;word-spacing:11.8px;}
#t6_4{left:58px;top:195px;letter-spacing:0.1px;word-spacing:25.5px;}
#t7_4{left:58px;top:213px;word-spacing:9.7px;}
#t8_4{left:58px;top:231px;letter-spacing:0.1px;word-spacing:19.9px;}
#t9_4{left:58px;top:249px;word-spacing:15.8px;}
#ta_4{left:58px;top:268px;word-spacing:11.3px;}
#tb_4{left:58px;top:286px;letter-spacing:0.1px;word-spacing:5.3px;}
#tc_4{left:58px;top:304px;letter-spacing:0.1px;word-spacing:11.7px;}
#td_4{left:58px;top:322px;word-spacing:5.5px;}
#te_4{left:58px;top:341px;letter-spacing:0.1px;word-spacing:4.1px;}
#tf_4{left:58px;top:359px;word-spacing:7.2px;}
#tg_4{left:58px;top:377px;word-spacing:18.9px;}
#th_4{left:58px;top:395px;letter-spacing:0.1px;word-spacing:5px;}
#ti_4{left:294px;top:394px;}
#tj_4{left:76px;top:414px;word-spacing:7.6px;}
#tk_4{left:58px;top:432px;word-spacing:21px;}
#tl_4{left:58px;top:450px;letter-spacing:0.1px;word-spacing:20.2px;}
#tm_4{left:322px;top:449px;}
#tn_4{left:337px;top:450px;word-spacing:20.2px;}
#to_4{left:58px;top:469px;word-spacing:12.5px;}
#tp_4{left:58px;top:487px;letter-spacing:0.1px;word-spacing:24.1px;}
#tq_4{left:58px;top:505px;letter-spacing:0.2px;}
#tr_4{left:81px;top:503px;}
#ts_4{left:100px;top:505px;word-spacing:11.7px;}
#tt_4{left:58px;top:523px;word-spacing:4px;}
#tu_4{left:58px;top:542px;word-spacing:22.6px;}
#tv_4{left:58px;top:560px;word-spacing:3.4px;}
#tw_4{left:58px;top:578px;word-spacing:12.1px;}
#tx_4{left:58px;top:596px;word-spacing:27px;}
#ty_4{left:58px;top:615px;word-spacing:3.2px;}
#tz_4{left:76px;top:633px;letter-spacing:0.1px;word-spacing:14.4px;}
#t10_4{left:58px;top:651px;letter-spacing:0.1px;}
#t11_4{left:171px;top:651px;}
#t12_4{left:220px;top:651px;letter-spacing:0.1px;}
#t13_4{left:299px;top:651px;letter-spacing:0.1px;}
#t14_4{left:393px;top:651px;}
#t15_4{left:58px;top:669px;letter-spacing:0.1px;word-spacing:26.3px;}
#t16_4{left:58px;top:688px;word-spacing:27.6px;}
#t17_4{left:58px;top:706px;letter-spacing:0.1px;word-spacing:14.1px;}
#t18_4{left:58px;top:724px;word-spacing:8.8px;}
#t19_4{left:58px;top:742px;word-spacing:23.6px;}
#t1a_4{left:58px;top:761px;letter-spacing:0.1px;word-spacing:5.7px;}
#t1b_4{left:58px;top:779px;letter-spacing:0.1px;word-spacing:5.2px;}
#t1c_4{left:58px;top:797px;word-spacing:8.6px;}
#t1d_4{left:58px;top:815px;letter-spacing:0.1px;word-spacing:16.9px;}
#t1e_4{left:58px;top:834px;letter-spacing:0.1px;}
#t1f_4{left:90px;top:832px;}
#t1g_4{left:76px;top:852px;word-spacing:4px;}
#t1h_4{left:58px;top:870px;word-spacing:13.4px;}
#t1i_4{left:58px;top:889px;word-spacing:10.9px;}
#t1j_4{left:58px;top:907px;word-spacing:20.5px;}
#t1k_4{left:58px;top:925px;word-spacing:1.3px;}
#t1l_4{left:460px;top:103px;word-spacing:27.1px;}
#t1m_4{left:460px;top:121px;word-spacing:17px;}
#t1n_4{left:460px;top:140px;word-spacing:14.1px;}
#t1o_4{left:747px;top:138px;}
#t1p_4{left:766px;top:140px;word-spacing:14.1px;}
#t1q_4{left:460px;top:158px;word-spacing:17.8px;}
#t1r_4{left:460px;top:176px;word-spacing:4.8px;}
#t1s_4{left:460px;top:195px;word-spacing:5.2px;}
#t1t_4{left:478px;top:213px;letter-spacing:0.1px;word-spacing:8.1px;}
#t1u_4{left:460px;top:231px;word-spacing:37.8px;}
#t1v_4{left:460px;top:249px;word-spacing:16.3px;}
#t1w_4{left:460px;top:268px;word-spacing:11.8px;}
#t1x_4{left:460px;top:286px;word-spacing:12.2px;}
#t1y_4{left:460px;top:304px;word-spacing:27.3px;}
#t1z_4{left:460px;top:322px;word-spacing:5.2px;}
#t20_4{left:478px;top:341px;letter-spacing:0.1px;word-spacing:3.6px;}
#t21_4{left:460px;top:359px;word-spacing:23.6px;}
#t22_4{left:460px;top:377px;word-spacing:10.5px;}
#t23_4{left:460px;top:395px;word-spacing:5.4px;}
#t24_4{left:460px;top:414px;word-spacing:12.9px;}
#t25_4{left:460px;top:432px;word-spacing:10.5px;}
#t26_4{left:460px;top:450px;word-spacing:5.3px;}
#t27_4{left:460px;top:469px;letter-spacing:0.1px;word-spacing:-0.7px;}
#t28_4{left:460px;top:487px;word-spacing:15.8px;}
#t29_4{left:812px;top:485px;}
#t2a_4{left:460px;top:505px;word-spacing:7.4px;}
#t2b_4{left:460px;top:523px;word-spacing:1.8px;}
#t2c_4{left:460px;top:542px;word-spacing:1.9px;}
#t2d_4{left:460px;top:560px;word-spacing:14.1px;}
#t2e_4{left:460px;top:578px;word-spacing:23.9px;}
#t2f_4{left:460px;top:596px;word-spacing:27.1px;}
#t2g_4{left:460px;top:615px;word-spacing:6.6px;}
#t2h_4{left:460px;top:633px;word-spacing:3.9px;}
#t2i_4{left:460px;top:651px;word-spacing:12.2px;}
#t2j_4{left:460px;top:669px;word-spacing:0.5px;}
#t2k_4{left:460px;top:723px;}
#t2l_4{left:460px;top:742px;word-spacing:0.7px;}
#t2m_4{left:460px;top:761px;word-spacing:29.1px;}
#t2n_4{left:460px;top:779px;word-spacing:15.2px;}
#t2o_4{left:460px;top:797px;letter-spacing:0.1px;word-spacing:18.9px;}
#t2p_4{left:460px;top:815px;word-spacing:12.1px;}
#t2q_4{left:460px;top:834px;word-spacing:21.5px;}
#t2r_4{left:460px;top:852px;word-spacing:7.8px;}
#t2s_4{left:460px;top:870px;word-spacing:15.8px;}
#t2t_4{left:460px;top:889px;word-spacing:9.5px;}
#t2u_4{left:460px;top:907px;word-spacing:-0.3px;}
#t2v_4{left:460px;top:925px;}
#t2w_4{left:58px;top:989px;letter-spacing:0.1px;}
#t2x_4{left:64px;top:1019px;letter-spacing:-0.2px;word-spacing:2.7px;}
#t2y_4{left:78px;top:1035px;word-spacing:14.7px;}
#t2z_4{left:78px;top:1050px;letter-spacing:-0.1px;word-spacing:4.8px;}
#t30_4{left:282px;top:1050px;}
#t31_4{left:78px;top:1065px;}
#t32_4{left:64px;top:1099px;word-spacing:16.7px;}
#t33_4{left:78px;top:1114px;letter-spacing:-0.3px;}
#t34_4{left:146px;top:1114px;}
#t35_4{left:191px;top:1114px;}
#t36_4{left:211px;top:1114px;}
#t37_4{left:245px;top:1114px;}
#t38_4{left:276px;top:1114px;}
#t39_4{left:78px;top:1129px;word-spacing:14.7px;}
#t3a_4{left:343px;top:1019px;word-spacing:31.3px;}
#t3b_4{left:473px;top:1019px;}
#t3c_4{left:527px;top:1019px;word-spacing:31.5px;}
#t3d_4{left:343px;top:1035px;word-spacing:3.8px;}
#t3e_4{left:455px;top:1035px;}
#t3f_4{left:472px;top:1035px;}
#t3g_4{left:329px;top:1059px;letter-spacing:-0.4px;word-spacing:13.9px;}
#t3h_4{left:343px;top:1074px;letter-spacing:-0.5px;word-spacing:-3.1px;}
#t3i_4{left:521px;top:1074px;letter-spacing:-0.2px;}
#t3j_4{left:541px;top:1074px;letter-spacing:-0.3px;}
#t3k_4{left:329px;top:1099px;letter-spacing:-0.1px;word-spacing:5px;}
#t3l_4{left:343px;top:1114px;word-spacing:4.2px;}
#t3m_4{left:343px;top:1129px;word-spacing:4px;}
#t3n_4{left:499px;top:1129px;}
#t3o_4{left:522px;top:1129px;}
#t3p_4{left:594px;top:1019px;word-spacing:7.4px;}
#t3q_4{left:608px;top:1035px;word-spacing:8px;}
#t3r_4{left:608px;top:1050px;word-spacing:7.1px;}
#t3s_4{left:608px;top:1065px;}
#t3t_4{left:625px;top:1065px;}
#t3u_4{left:594px;top:1099px;word-spacing:18.8px;}
#t3v_4{left:608px;top:1114px;word-spacing:9.8px;}
#t3w_4{left:608px;top:1129px;word-spacing:9.5px;}
#t3x_4{left:58px;top:36px;}
#t3y_4{left:155px;top:36px;word-spacing:4.8px;}

.s7_4{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: IIBMDK-AdvPSA35F4;
	color: rgb(0,0,0);
}

.s5_4{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: IIBMFB-AdvPS_UVCL4;
	color: rgb(0,0,0);
}

.s8_4{
	FONT-SIZE: 54.8px;
	FONT-FAMILY: IIBMGE-AdvPSA35B4;
	color: rgb(0,0,0);
}

.s3_4{
	FONT-SIZE: 67px;
	FONT-FAMILY: IIBMDK-AdvPSA35F4;
	color: rgb(0,0,0);
}

.s4_4{
	FONT-SIZE: 73.1px;
	FONT-FAMILY: IIBMDK-AdvPSA35F4;
	color: rgb(0,0,0);
}

.s6_4{
	FONT-SIZE: 48.7px;
	FONT-FAMILY: IIBNJA-AdvOTda3b4f5f-B4;
	color: rgb(0,0,0);
}

.s2_4{
	FONT-SIZE: 40.6px;
	FONT-FAMILY: IIBMDN-AdvPSNCS-R4;
	color: rgb(0,0,0);
}

.s1_4{
	FONT-SIZE: 60.9px;
	FONT-FAMILY: IIBMDN-AdvPSNCS-R4;
	color: rgb(0,0,0);
}

.v1_4{
	-webkit-transform: scale(0.281, 0.25);
	-ms-transform: scale(0.281, 0.25);
	-moz-transform: scale(0.281, 0.25);
	-o-transform: scale(0.281, 0.25);
}

#form4_1{	border-style:none;	z-index:2;	position: absolute;	left:321px;	top:445px;	width:8px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_2{	border-style:none;	z-index:2;	position: absolute;	left:81px;	top:500px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_3{	border-style:none;	z-index:2;	position: absolute;	left:294px;	top:390px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_4{	border-style:none;	z-index:2;	position: absolute;	left:746px;	top:135px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_5{	border-style:none;	z-index:2;	position: absolute;	left:811px;	top:481px;	width:14px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}
#form4_6{	border-style:none;	z-index:2;	position: absolute;	left:89px;	top:828px;	width:15px;	height:17px;	text-align:left;	background: transparent;	font:normal 12px Arial, Helvetica, sans-serif;}

</style>
<style id="fonts4" type="text/css" >

@font-face {
	font-family: IIBMDN-AdvPSNCS-R4;
	src: url("4/fonts/IIBMDN-AdvPSNCS-R.woff") format("woff");
}

@font-face {
	font-family: IIBMGE-AdvPSA35B4;
	src: url("4/fonts/IIBMGE-AdvPSA35B.woff") format("woff");
}

@font-face {
	font-family: IIBMDK-AdvPSA35F4;
	src: url("4/fonts/IIBMDK-AdvPSA35F.woff") format("woff");
}

@font-face {
	font-family: IIBNJA-AdvOTda3b4f5f-B4;
	src: url("4/fonts/IIBNJA-AdvOTda3b4f5f-B.woff") format("woff");
}

@font-face {
	font-family: IIBMFB-AdvPS_UVCL4;
	src: url("4/fonts/IIBMFB-AdvPS_UVCL.woff") format("woff");
}

</style>
<div id="t1_4" class="t s1_4">testosterone for evaluating the efFcacy of TST in an</div>
<div id="t2_4" class="t s1_4">individual.</div>
<div id="t3_4" class="t s1_4">Most patients are treated with testosterone gels</div>
<div id="t4_4" class="t s1_4">or injections for symptomatic hypogonadism. ±ewer</div>
<div id="t5_4" class="t s1_4">men currently receive CC as an alternative treat-</div>
<div id="t6_4" class="t s1_4">ment for hypogonadism. Overall in the current</div>
<div id="t7_4" class="t s1_4">study men who received CC reported hypogonadal</div>
<div id="t8_4" class="t s1_4">symptom resolution rates via qADAM that were</div>
<div id="t9_4" class="t s1_4">equal to those of men prescribed testosterone in-</div>
<div id="ta_4" class="t s1_4">jections or gels. This evidence suggests that there</div>
<div id="tb_4" class="t s1_4">may be a larger role for CC as treatment for symp-</div>
<div id="tc_4" class="t s1_4">tomatic hypogonadism as an alternative to testos-</div>
<div id="td_4" class="t s1_4">terone gels or injections, especially in younger men</div>
<div id="te_4" class="t s1_4">interested in preserving fertility. Of concern is that</div>
<div id="tf_4" class="t s1_4">up to 20% of urologists prescribe exogenous testos-</div>
<div id="tg_4" class="t s1_4">terone, a medication known for its contraceptive</div>
<div id="th_4" class="t s1_4">potential, in men with infertility.</div>
<div id="ti_4" class="t v1_4 s2_4">24</div>
<div id="tj_4" class="t s1_4">The Fndings of this study dispel the notion that</div>
<div id="tk_4" class="t s1_4">a pure linear relationship exists between serum</div>
<div id="tl_4" class="t s1_4">testosterone and satisfaction levels.</div>
<div id="tm_4" class="t v1_4 s2_4">4</div>
<div id="tn_4" class="t s1_4">In a recent</div>
<div id="to_4" class="t s1_4">study Yeap et al observed a U-shaped association</div>
<div id="tp_4" class="t s1_4">between testosterone and cardiovascular mortal-</div>
<div id="tq_4" class="t s1_4">ity.</div>
<div id="tr_4" class="t v1_4 s2_4">25</div>
<div id="ts_4" class="t s1_4">Men with serum testosterone in the highest</div>
<div id="tt_4" class="t s1_4">quartile were at higher risk for mortality than men</div>
<div id="tu_4" class="t s1_4">in the middle quartiles. With studies indicating</div>
<div id="tv_4" class="t s1_4">an association between serum testosterone and car-</div>
<div id="tw_4" class="t s1_4">diovascular risk practitioners should target symp-</div>
<div id="tx_4" class="t s1_4">tom improvement rather than simply increased</div>
<div id="ty_4" class="t s1_4">testosterone as the end goal.</div>
<div id="tz_4" class="t s1_4">Interestingly, when components of the qADAM</div>
<div id="t10_4" class="t s1_4">questionnaire</div>
<div id="t11_4" class="t s1_4">were</div>
<div id="t12_4" class="t s1_4">analyzed</div>
<div id="t13_4" class="t s1_4">separately,</div>
<div id="t14_4" class="t s1_4">men</div>
<div id="t15_4" class="t s1_4">receiving testosterone injections reported higher</div>
<div id="t16_4" class="t s1_4">libido than men receiving CC and testosterone</div>
<div id="t17_4" class="t s1_4">gels. ±urthermore, serum estradiol was higher in</div>
<div id="t18_4" class="t s1_4">men on testosterone injections than in men on CC</div>
<div id="t19_4" class="t s1_4">or testosterone gels. These associations between</div>
<div id="t1a_4" class="t s1_4">increased serum estradiol and higher libido corrob-</div>
<div id="t1b_4" class="t s1_4">orate the recent study by ±inkelstein et al showing</div>
<div id="t1c_4" class="t s1_4">an important role for estrogen in the regulation of</div>
<div id="t1d_4" class="t s1_4">sexual function in men treated with testosterone</div>
<div id="t1e_4" class="t s1_4">gels.</div>
<div id="t1f_4" class="t v1_4 s2_4">26</div>
<div id="t1g_4" class="t s1_4">The current study has strengths and limitations.</div>
<div id="t1h_4" class="t s1_4">The ability to capture men on the same day that</div>
<div id="t1i_4" class="t s1_4">serum hormones were evaluated allowed for accu-</div>
<div id="t1j_4" class="t s1_4">rate comparisons between serum hormone levels</div>
<div id="t1k_4" class="t s1_4">and perceived symptomology. Also, the age matched</div>
<div id="t1l_4" class="t s1_4">design removed age as a confounding variable,</div>
<div id="t1m_4" class="t s1_4">which is especially important since younger men</div>
<div id="t1n_4" class="t s1_4">report increased satisfaction with TST.</div>
<div id="t1o_4" class="t v1_4 s2_4">27</div>
<div id="t1p_4" class="t s1_4">In addi-</div>
<div id="t1q_4" class="t s1_4">tion, CC was typically prescribed for young men</div>
<div id="t1r_4" class="t s1_4">with infertility and age matching would potentially</div>
<div id="t1s_4" class="t s1_4">eliminate this bias.</div>
<div id="t1t_4" class="t s1_4">We sought to identify differences, if any, among</div>
<div id="t1u_4" class="t s1_4">TST modalities by evaluating symptoms from</div>
<div id="t1v_4" class="t s1_4">the patient perspective. Using a control group of</div>
<div id="t1w_4" class="t s1_4">eugonadal men not on TST and the standardized,</div>
<div id="t1x_4" class="t s1_4">validated qADAM questionnaire to evaluate satis-</div>
<div id="t1y_4" class="t s1_4">faction and hypogonadal symptoms add further</div>
<div id="t1z_4" class="t s1_4">strength to our Fndings.</div>
<div id="t20_4" class="t s1_4">The study was limited by its retrospective, cross-</div>
<div id="t21_4" class="t s1_4">sectional design and the fact that pretreatment</div>
<div id="t22_4" class="t s1_4">qADAM values were not available. A limitation of</div>
<div id="t23_4" class="t s1_4">qADAM is poor speciFcity. The lack of speciFcity is</div>
<div id="t24_4" class="t s1_4">due not only to the fact that many positive ques-</div>
<div id="t25_4" class="t s1_4">tionnaire responses may indicate other conditions,</div>
<div id="t26_4" class="t s1_4">such as depression, but also because scores derived</div>
<div id="t27_4" class="t s1_4">from these questionnaires do not predict or correlate</div>
<div id="t28_4" class="t s1_4">well with measured free and total testosterone.</div>
<div id="t29_4" class="t v1_4 s2_4">28</div>
<div id="t2a_4" class="t s1_4">Moreover, while we could not control the timing of</div>
<div id="t2b_4" class="t s1_4">testosterone injection, which could have confounded</div>
<div id="t2c_4" class="t s1_4">the results, the fact that average testosterone levels</div>
<div id="t2d_4" class="t s1_4">were signiFcantly increased compared to those in</div>
<div id="t2e_4" class="t s1_4">patients who received CC and testosterone gels</div>
<div id="t2f_4" class="t s1_4">suggests that most patient data were captured</div>
<div id="t2g_4" class="t s1_4">within 3 or 4 days after injection. In addition, only</div>
<div id="t2h_4" class="t s1_4">1 serum testosterone measurement was included in</div>
<div id="t2i_4" class="t s1_4">analysis since we sought to evaluate the relation-</div>
<div id="t2j_4" class="t s1_4">ship between qADAM score and serum testosterone.</div>
<div id="t2k_4" class="t s3_4">CONCLUSIONS</div>
<div id="t2l_4" class="t s1_4">Men on CC for symptomatic hypogonadism reported</div>
<div id="t2m_4" class="t s1_4">hypogonadal symptoms similar to those of age</div>
<div id="t2n_4" class="t s1_4">matched men on testosterone injections and gels.</div>
<div id="t2o_4" class="t s1_4">These comparable hypogonadal symptoms among</div>
<div id="t2p_4" class="t s1_4">the different treatment regimens suggest that CC</div>
<div id="t2q_4" class="t s1_4">could be as effective for hypogonadism as other</div>
<div id="t2r_4" class="t s1_4">well established treatment modalities. Because CC</div>
<div id="t2s_4" class="t s1_4">has fewer potential side effects than testosterone</div>
<div id="t2t_4" class="t s1_4">injections or gels and it is more affordable, it may</div>
<div id="t2u_4" class="t s1_4">have a larger role in treating men with symptomatic</div>
<div id="t2v_4" class="t s1_4">hypogonadism.</div>
<div id="t2w_4" class="t s4_4">REFERENCES</div>
<div id="t2x_4" class="t s5_4">1. Mulligan T, Frick MF, Zuraw QC et al: Prevalence</div>
<div id="t2y_4" class="t s5_4">of hypogonadism in males aged at least 45</div>
<div id="t2z_4" class="t s5_4">years: the HIM study. Int J Clin Pract 2006;</div>
<div id="t30_4" class="t s6_4">60:</div>
<div id="t31_4" class="t s5_4">762.</div>
<div id="t32_4" class="t s5_4">2. Bhasin S, Cunningham GR, Hayes FJ et al:</div>
<div id="t33_4" class="t s5_4">Testosterone</div>
<div id="t34_4" class="t s5_4">therapy</div>
<div id="t35_4" class="t s5_4">in</div>
<div id="t36_4" class="t s5_4">adult</div>
<div id="t37_4" class="t s5_4">men</div>
<div id="t38_4" class="t s5_4">with</div>
<div id="t39_4" class="t s5_4">androgen deficiency syndromes: an endocrine</div>
<div id="t3a_4" class="t s5_4">society clinical practice</div>
<div id="t3b_4" class="t s5_4">guideline.</div>
<div id="t3c_4" class="t s5_4">J Clin</div>
<div id="t3d_4" class="t s5_4">Endocrinol Metab 2006;</div>
<div id="t3e_4" class="t s6_4">91:</div>
<div id="t3f_4" class="t s5_4">1995.</div>
<div id="t3g_4" class="t s5_4">3. Traish AM, Miner MM, Morgentaler A et al:</div>
<div id="t3h_4" class="t s5_4">Testosterone deficiency. Am J Med 2011;</div>
<div id="t3i_4" class="t s6_4">124:</div>
<div id="t3j_4" class="t s5_4">578.</div>
<div id="t3k_4" class="t s5_4">4. Wu FC, Tajar A, Beynon JM et al: Identification</div>
<div id="t3l_4" class="t s5_4">of late-onset hypogonadism in middle-aged and</div>
<div id="t3m_4" class="t s5_4">elderly men. N Engl J Med 2010;</div>
<div id="t3n_4" class="t s6_4">363:</div>
<div id="t3o_4" class="t s5_4">123.</div>
<div id="t3p_4" class="t s5_4">5. Kaufman JM and Vermeulen A: The decline of</div>
<div id="t3q_4" class="t s5_4">androgen levels in elderly men and its clinical</div>
<div id="t3r_4" class="t s5_4">and therapeutic implications. Endocr Rev 2005;</div>
<div id="t3s_4" class="t s6_4">26:</div>
<div id="t3t_4" class="t s5_4">833.</div>
<div id="t3u_4" class="t s5_4">6. Hak AE, Witteman JC, de Jong FH et al:</div>
<div id="t3v_4" class="t s5_4">Low levels of endogenous androgens increase</div>
<div id="t3w_4" class="t s5_4">the risk of atherosclerosis in elderly men: the</div>
<div id="t3x_4" class="t s7_4">878</div>
<div id="t3y_4" class="t s8_4">TESTOSTERONE SUPPLEMENTATION VERSUS CLOMIPHENE CITRATE FOR HYPOGONADISM</div>

<form>
<input type="button"  tabindex="2"  id="form4_1" name="32 0 R"  pdfFieldName="32 0 R" onclick="window.location.href='4.html';" style="cursor:pointer;"  title="Page 4" />
<input type="button"  tabindex="3"  id="form4_2" name="33 0 R"  pdfFieldName="33 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="1"  id="form4_3" name="31 0 R"  pdfFieldName="31 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="5"  id="form4_4" name="35 0 R"  pdfFieldName="35 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="6"  id="form4_5" name="36 0 R"  pdfFieldName="36 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />
<input type="button"  tabindex="4"  id="form4_6" name="34 0 R"  pdfFieldName="34 0 R" onclick="window.location.href='5.html';" style="cursor:pointer;"  title="Page 5" />

</form>
<div id="pg4Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg4"><object width="893" height="1196" data="4/4.svg" type="image/svg+xml" id="pdf4" style="width:893px; height:1196px; background-color:white; -moz-transform:scale(1); z-index: 0;"></object></div>
<!--[if lt IE 9]><script type="text/javascript">
var divCount = 143;
for (var i = 1; i < divCount; i++) {
    var div = document.getElementById("t" + i.toString(36) + "_4");
    if (div !== null) {
        div.style.top = (div.offsetTop * 4) + "px";
        div.style.left = (div.offsetLeft * 4) + "px";
        div.style.zoom = "25%";
    }
}
</script><![endif]-->

</div>
